Dr. Beth Anne Schrope, MD

Dr. Schrope practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Schrope's NPI, 1003885997, was assigned on March 14, 2006. Dr. Schrope graduated from Lewis Katz School of Medicine in 1996. Dr. Schrope holds New York license 212838.

Dr. Schrope's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Schrope's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Schrope is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Schrope to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schrope practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Schrope's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Schrope is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Schrope's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists colon removal, esophagus, stomach, or upper small intestine surgery and gallbladder removal among the conditions Dr. Schrope treats.

CMS data shows 97 Medicare services from Dr. Schrope across 3 procedure codes in 2024, all of them office visits, for 146 Medicare patients. Medicare paid $9,339 for them. Every service was in an office.

CMS counts 146 Medicare patients who saw Dr. Schrope in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schrope's median patient age at 66, with 62% women.

In 2024, Dr. Schrope wrote 54 Medicare Part D claims for 33 patients. 78% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $1,923 in total drug cost. In 2020, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Schrope for performance year 2024, reported through an alternative payment model (APM). Dr. Schrope accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schrope as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 74 papers to Dr. Schrope, published from 2005 to 2024. 2021 was the busiest year, with 6. The most frequent topics are Pancreatic Neoplasms, Pancreatectomy and Postoperative Complications. Dr. Schrope has published most often in J Gastrointest Surg. Dr. Schrope's most frequent co-authors are John A. Chabot, MD, Michael D. Kluger, MD, MPH and John Dennis Allendorf, MD.

CMS Open Payments shows 90 general payments to Dr. Schrope from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Ethicon Inc. paid the most, $24,517.

Dmand AI lists 4 awards for Dr. Schrope, most recently Nobility in Science in 2017.

Dr. Schrope graduated from Lewis Katz School of Medicine in 1996. Dr. Schrope is a member of AHPBA, ACS, SSAT, SAGES and SLS.

Dr. Schrope is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.